← Open Payments lookup

SARAH KASSIN: Open Payments

NPI 1205484219 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,209 in 66 payments from 10 companies in 2025. Trend: 2023 $1,305 · 2024 $1,244 · 2025 $1,209

Food & beverage: $1,209
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$278
Alkermes, Inc.14$192
Lundbeck LLC8$184
Vanda Pharmaceuticals Inc.9$175
ABBVIE INC.10$150
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$130
Teva Pharmaceuticals USA, Inc.2$40
Janssen Pharmaceuticals, Inc1$23
Luye Pharma (USA) Ltd.1$21
E.R. Squibb & Sons, L.L.C.1$17

Products named: REXULTI, ARISTADA, VRAYLAR, HETLIOZ, CAPLYTA, ABILIFY MAINTENA, AUSTEDO XR, FANAPT.

Industry payments across KS — which companies pay providers there.